There is a need to curtail the misuse of antibiotics, environmental activists deliberated during a meeting of several state representatives developing an action plan on antimicrobial resistance (AMR), a disease which makes consumers immune to antibiotics.
"We need to get our act together to stop the misuse of antibiotics in humans and animals. The experts at the meeting have shown how we can do this. We have a road map for Kerala under which antibiotics used for growth promotion and disease prevention could be phased-out in 3-5 years.
"We can also stop the use of antibiotics in animal feed and ban last-resort antibiotics like Colistin immediately. If Kerala can do it, so can other states," said Chandra Bhushan, the deputy director of environment think tank CSE, at a meeting held in Thiruvananthapuram with several states represented by their various departments.
The meeting saw participation from states including Uttar Pradesh, Odisha, Kerala, Madhya Pradesh, Maharashtra, Telangana, Tamil Nadu, Karnataka, Andhra Pradesh and Delhi to deliberate on fighting AMR and formulating an action plan for it.
So far, Kerala is the only state which in October 2018 released its plan - 'Kerala Antimicrobial Resistance Strategic Action Plan', Centre for Science and Environment (CSE), said.
The deliberations were held at a two-day national workshop which was jointly-organised by the CSE, based in New Delhi, and the Department of Health and Family Welfare, Kerala. It saw participation from various state departments such as of health, animal husbandry, fisheries, food, drug, agriculture and pollution control.
Antimicrobial resistance or AMR is a global public health crisis which apart from huge health and economic losses to individuals and nations, is expected to impact the attainment of several sustainable development goals, a statement released by CSE said.
"As a result of growing AMR, the world is running out of antibiotics as they are becoming ineffective. Infectious diseases are getting difficult to treat or untreatable.
"There are no new antibiotics in the market and those used as a last-resort are also failing. AMR is known to accelerate due to overuse and misuse of antibiotics in human health, food-animal production and agriculture along with inadequate waste management from households, farms, factories and health care settings," it said.
States have a critical role in India's fight against AMR as they know the ground realities and are responsible for managing human health, animal husbandry and environment. What they need is a comprehensive and implementable action plan on AMR, Bhushan said.
Speaking at the meeting, Rajan Khobragade, the principal secretary at the department of health and family welfare, Kerala, said, "Kerala's action plan includes all necessary aspects to contain AMR. We are happy that we could share our learning with other states through this important workshop."
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
